466 filings
Page 16 of 24
S-8
58t3mb 3m66f1kfjjnl
10 Apr 15
Registration of securities for employees
12:00am
CT ORDER
sy8h7x ujc56
1 Apr 15
Confidential treatment order
12:00am
DEFA14A
6272dtfowg29x uauvwi
19 Mar 15
Additional proxy soliciting materials
12:00am
8-K/A
zxqxqp4pzp z3ffc
13 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
2nk83li77vyxja
26 Feb 15
NewLink Genetics Corporation Provides Operational Update and Reports Fourth Quarter and Year End 2014 Financial Results
12:00am
8-K
9t17vb0
19 Feb 15
NewLink Genetics Corporation Announces Clinical Development Milestone Achieved with Merck for Ebola Vaccine Candidate
12:00am
CT ORDER
veb 4plddxpxm0tywx
13 Jan 15
Confidential treatment order
12:00am
8-K
ryclbe4jehn o54hz
6 Jan 15
Departure of Directors or Certain Officers
12:00am
8-K
tkeobnv8x669mz
22 Dec 14
NewLink Genetics, Merck Collaboration to Manufacture Ebola Vaccine Candidate Supported by $30 Million Government Award
12:00am
CT ORDER
djytzh1dz8wr6d24
9 Dec 14
Confidential treatment order
12:00am
8-K
ugo 7lwob
24 Nov 14
Merck and NewLink Genetics Enter into Licensing and Collaboration Agreement for Investigational Ebola Vaccine
12:00am
8-K
gygjnahbwucg3e0w
17 Nov 14
Other Events
12:00am
8-K
uda2dnhtcnq68308
14 Nov 14
Other Events
12:00am
8-K
l0f dex5vr3erl
6 Nov 14
NewLink Genetics Corporation Reports Third Quarter 2014 Financial Results
12:00am
8-K
03losws25n4szz
20 Oct 14
Entry into a Material Definitive Agreement
12:00am
8-K
itgatge7kil
1 Oct 14
NewLink Genetics Corporation Announces Appointment of New Executive Vice President and Chief Financial Officer
12:00am
8-K
161y3 73r6e
4 Sep 14
FDA Gives NewLink Genetics Approval to Proceed to Phase 1 Clinical Studies of their Ebola Vaccine
12:00am